Despite a highly profitable business model and a strong position in the medical aesthetics industry, INMD stock is down -33% over the last 12 months. Macroeconomic pressures, political risks in InMode ...

DUBLIN--(BUSINESS WIRE)--The "Body Contouring Devices Market Size, Share & Trends Analysis Report by Type (Noninvasive and Minimally Invasive Devices, Invasive Devices), by Application, by Region, and ...

Despite INMD being down -22% since I recommended to Buy the stock in March, InMode Ltd. remains a highly profitable & innovative leader in the aesthetic industry. Stronger than expected macroeconomic ...

NEW YORK, Jan. 20, 2020 /PRNewswire/ -- bodySCULPT® the premier plastic surgery practice based in New York City, NY, announces two breakthrough non-invasive solutions from InMode - EVOKE, a complete ...

Founded in 2008, InMode Ltd. (NASDAQ:INMD) provides energy-based, minimally invasive surgical and medical treatment solutions. The categories that are addressed by the products of InMode Ltd.

The body contouring treatments market is segmented based on technology into invasive and non-invasive technologies—the non-invasive segment is expected to hold major share of the market in 2023. The ...